Active: new fund May 2026 Verified 4 Nov 2026
Advent Life Sciences
London life sciences venture and growth investor that starts and funds early and mid-stage companies in drug discovery, medtech, enabling technologies and vaccines across the UK, Europe and the US.
- Type
- VC firm
- Location
- London, United Kingdom
- Stages
- Seed, Series A, Series B, Growth
- Backs
- Biotech and pharma
- Sectors
- Healthtech and life sciences, Biotech
- Portfolio mix
- Biotech and pharma 82%; Medtech and digital health 12%; B2B software 4%; Hardware 2% (n=29)
- Website
- adventls.com
Contacts on file
For Advent Life Sciences, the paid file holds: 8 named decision-makers with roles; firm contact email (domain checked); LinkedIn page.
Get UK Complete, $149 Free sample
One-time payment. No subscription. No account.
Notable investments
AlgetaAvilaAxonicsAviadoBioAmphista
Sources
Last checked 4 Nov 2026. Is something wrong? Tell us.
Appears in 27 lists
Biotech investors in London (42)Series B investors in the UK (54)Active startup investors in the UK (73)Series B biotech investors (73)Biotech investors in the UK (92)Growth-stage biotech investors (109)Healthtech investors in London (113)Growth-stage investors in the UK (137)Venture capital firms in London (149)Series A biotech investors (153)Series A investors in the UK (154)Series B healthtech investors (160)Venture capital firms in the UK (192)Healthtech investors in the UK (194)Startup investors in London (239)Seed investors in the UK (295)Seed biotech investors (300)Growth-stage healthtech investors (316)Series B investors (339)Series A healthtech investors (401)Startup investors in the UK (416)Biotech investors (484)Growth-stage investors (705)Seed healthtech investors (800)Series A investors (864)Healthtech investors (1,207)Seed investors (1,892)